Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
218.6 USD | -0.64% | +2.22% | +27.06% |
Financials (USD)
Sales 2024 * | 4.68B | Sales 2025 * | 5.03B | Capitalization | 32.11B |
---|---|---|---|---|---|
Net income 2024 * | 1.02B | Net income 2025 * | 1.23B | EV / Sales 2024 * | 6.99 x |
Net Debt 2024 * | 592M | Net cash position 2025 * | 384M | EV / Sales 2025 * | 6.3 x |
P/E ratio 2024 * |
31.5
x | P/E ratio 2025 * |
26.6
x | Employees | 10,140 |
Yield 2024 * |
0.9% | Yield 2025 * |
0.98% | Free-Float | 76.96% |
Latest transcript on ResMed, Inc.
1 day | -0.64% | ||
1 week | +2.22% | ||
Current month | +2.14% | ||
1 month | +25.74% | ||
3 months | +21.12% | ||
6 months | +46.75% | ||
Current year | +27.06% |
Managers | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 00-08-31 |
Peter Farrell
FOU | Founder | 81 | 89-05-31 |
Brett Sandercock
DFI | Director of Finance/CFO | 57 | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 00-08-31 |
Ron Taylor
BRD | Director/Board Member | 76 | 04-12-31 |
Peter Farrell
FOU | Founder | 81 | 89-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.09% | 17 M€ | +7.73% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 218.6 | -0.64% | 450,553 |
24-05-16 | 220 | -0.30% | 649,042 |
24-05-15 | 220.6 | +2.21% | 649,462 |
24-05-14 | 215.8 | -0.94% | 724,855 |
24-05-13 | 217.9 | +1.90% | 781,052 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.06% | 32.11B | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- RMD Stock